HEPTARES
Live / Registered — Registered — Section 71 accepted (as of 29 Nov 2018)
What this means for you
Registered since 04 Nov 2008. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79040354
- Registration number
- 3527699
- Mark type
- Stylized text
- Filed
- 13 Jun 2007
- Published for opposition
- 19 Aug 2008
- Registered
- 04 Nov 2008
Goods and services
- Class 005 — Pharmaceuticals: [ pharmaceutical preparations and substances for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system ]
- Class 042 — Scientific and technological services: bio-technology, pharmaceutical and scientific testing, research, and development; providing information in the fields of bio-technology and scientific testing
Owner
- Nxera Pharma Co., Ltd, JP
- Sosei Group Corporation, JP
- Heptares Therapeutics Limited, Cambridge, GB
- Heptares Therapeutics Limited, GB
- Heptares Therapeutics Limited, GB
Prosecution history
- 19 Feb 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 19 Feb 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 19 Feb 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 14 Jun 2024 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 04 Nov 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Nov 2019 — CHANGE OF OWNER RECEIVED FROM IB
- 21 Aug 2019 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 29 Jul 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 29 Nov 2018 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 29 Nov 2018 — REGISTERED-SEC.71 ACCEPTED
- 29 Nov 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Nov 2018 — TEAS SECTION 71 RECEIVED
- 29 Jun 2017 — INTERNATIONAL REGISTRATION RENEWED
- 23 Jun 2017 — NEW REPRESENTATIVE AT IB RECEIVED
- 24 Mar 2017 — PARTIAL INVALIDATION PROCESSED BY THE IB